Dose Escalation/ Expansion Study of CA-4948 as Monotherapy in Patients With Acute Myelogenous Leukemia (AML) or Myelodysplastic Syndrome (MDS)

NCT04278768 · clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
SUSPENDED
Status
366
Enrollment
INDUSTRY
Sponsor class

Stopped Dosing completed in all cohorts. Planning underway for potential additional patient cohorts.

Conditions

Interventions

Sponsor

Curis, Inc.